Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection

NCT02692963 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02692963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02692963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
February 28, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, plasmodium falciparum